Developer docs
API playgroundTry for free, no card

Search company profiles

Vitas-M Laboratory

Full company profile

uuid0027xtm

Namestring
Vitas-M Laboratory
Legal namestring
Vitas M Chemical Limited
Websiteurl
vitasmlab.biz
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Vitas-M Laboratory, legally Vitas M Chemical Limited, is a privately held Hong Kong-based supplier of small molecule chemical compounds for pharmaceutical and agrochemical research and development. Founded in 1998 by Irina Haywood and operating from Causeway Bay with 11–50 employees, the company has built a catalog of over 1,400,000 individual synthetic organic screening compounds, plus 20,000+ organic building blocks, a Rule-of-3-compliant fragment collection (Allium), three diversity libraries (10,000, 37,000, and 55,000 compounds), and more than 50 disease- and target-specific targeted libraries generated using in-house clustering and similarity-based computational algorithms.

The core technology is a curated physical chemical inventory packaged with online discovery tools. Researchers can access the catalog through a 24/7 self-service database (downloadable without registration), a property-based molecular search engine (filtering on H-bond donors, acceptors, rotatable bonds, rings, PSA, LogP, and molecular weight), SDF creation, and availability checking. Compounds are shipped worldwide via FedEx and UPS in dry powder or DMSO formats, with comprehensive documentation (SD files, packing lists, MSDS). In-house algorithms design diversity libraries by grouping molecules via clustering for maximal chemical-space coverage and generate targeted libraries using reference-compound similarity thresholds above 0.85 with Rule-of-Five compliance.

The commercial model is direct-to-researcher catalog sales with a quote-based pricing system (no publicly disclosed prices) and a secondary tier of professional services for custom database generation. Customers span pharmaceutical companies (Gilead Sciences, Eisai, Mochida), government translational research (NCATS), and academic institutions (Uppsala, University of Michigan, Griffith University, University of Eastern Finland) across at least nine countries. GTM combines self-service product-led growth with a dedicated sales email ([email protected]) for enterprise and custom orders. Revenue is not publicly disclosed and the company is bootstrapped with no institutional investors, parent company, or M&A activity on record.

Short descriptiontext

Vitas-M Laboratory (Vitas M Chemical Limited) is a Hong Kong-based, privately held supplier of small molecule screening compounds, building blocks, and fragment libraries for pharmaceutical, agrochemical, and academic drug discovery research, offering over 1.4 million compounds globally since 1998.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCauseway Bay, Hong Kong SAR China
HQ citystring
Causeway Bay
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
screening compounds, fragment libraries, organic building blocks, drug discovery compounds, small molecule libraries
Industry2 codes
1Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
CodeHLAAAIALPrimaryYes
2High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening)
CodeHLAAAIAAPrimaryNo
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Drug Discovery Chemical Compounds
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Screening Compounds Sales
TypeOne Time License
Description

Direct sale of individual screening compounds (STK/STL collection) in dry powder or DMSO formats. Full cherry-picking access to entire catalog of 1,400,000+ compounds for immediate delivery.

vitasmlab.biz
2Organic Building Blocks Sales
TypeOne Time License
Description

Sale of BBL collection containing 20,000+ synthetic organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available in pack sizes of 500mg, 1g, and 2g.

vitasmlab.biz
3Fragment Library Sales
TypeOne Time License
Description

Fragment-based drug discovery compounds (Allium collection) compliant with Rule of 3. Offered in various formats including 384-well plates and custom quantities.

vitasmlab.biz
4Special Database Downloads
TypeOne Time License
Description

Specialized diversity and targeted compound libraries available for download. Includes Diversity_Vitas-10000 (10,000 compounds), Diversity_Vitas-37000 (7,000 compounds), and Diversity_Vitas-55000 (55,000 compounds) plus disease-specific targeted libraries.

vitasmlab.biz
5Custom Compound Database Generation
TypeProfessional Services
Description

Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.

vitasmlab.biz
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure
Pricing details1 tier
1Request for Quotation (RFQ) system for compound orders
ModelOtherBilling cadencePay-as-you-go
Notes

Orders submitted via online system with standard format (STKxxxxxx or BBLxxxxxx IDs) and requested amounts. Pricing provided upon inquiry.

vitasmlab.biz
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1STK
Description

Stock screening compounds for biological assays and hit identification

vitasmlab.biz
+5 more records
Core offering1 text field

Vitas-M Laboratory supplies synthetic organic screening compounds, fragment libraries, and building blocks for small molecule drug discovery in the pharmaceutical and agrochemical industries. It offers a catalog of over 1,400,000 individual compounds along with diversity and disease-specific targeted libraries, delivered via self-service online download and direct courier shipping.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1.4 million compounds available for immediate shipment
+2 more records
Product overview1 text field

Vitas-M Laboratory operates as a chemical compound supplier offering multiple product collections that serve as foundational research tools for pharmaceutical and agrochemical drug discovery. The core portfolio consists of the STK/STL screening compounds collection (1,400,000+ compounds) for biological assays and hit identification, the BBL building blocks collection (20,000+ compounds) for combinatorial and medicinal chemistry synthesis, and the Allium fragment collection for fragment-based drug discovery. These foundational products are complemented by specialized databases including three diversity libraries (Diversity_Vitas-10000, Diversity_Vitas-37000, Diversity_Vitas-55000) that provide structurally diverse compound sets with up to 55,000 molecules, and over 50 disease/target-specific targeted libraries designed using computational algorithms. The company provides online search tools, downloadable SDF files, and multiple delivery formats (dry powder, DMSO solutions, plates) to support researchers across the drug discovery workflow.

Product and service8 records
1STK/STL Collection (Screening Compounds)
CategoryScreening Compounds
Description

Stock of over 1,400,000 synthetic organic screening compounds available for immediate delivery, suitable for high-throughput screening, lead optimization, and medicinal chemistry workflows. Available in dry powder or DMSO solution formats.

2Allium Fragment Collection
CategoryFragment Library
Description

Stock of fragments for Fragment Based Drug Discovery, compiled on the basis of Rule of 3 (Molecular weight < 300, ClogP < 3, H-bond donors < 3, H-bond acceptors < 3) and proprietary filters. Available as dry powder or DMSO solutions in various formats including 384-well plates.

3BBL Collection (Building Blocks)
CategoryOrganic Building Blocks
Description

Collection of more than 20,000 organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available as dry powder in 500mg, 1g and 2g pack sizes.

4Diversity_Vitas-10000
CategoryDiversity Library
Description

Diversity library of 10,000 compounds designed for smaller-scale screening assays, emphasizing structural diversity using advanced clustering algorithms that group molecules by structural similarity.

5Diversity_Vitas-37000
CategoryDiversity Library
Description

Expanded diversity collection of 7,000 compounds offering greater variety of pharmacophores and structural motifs for medium- to high-throughput screening efforts.

6Diversity_Vitas-55000
CategoryDiversity Library
Description

Diversity library of 55,000 compounds incorporating wildcard molecules with unique or unconventional structures excluded from smaller libraries, designed for phenotypic screening and fragment-based discovery.

7Targeted Libraries (disease/target-specific)
CategoryTargeted Library
Description

Over 50 targeted molecular libraries designed using computational algorithms based on similarities with known active compounds. Libraries include Alzheimer's Disease, Cancer, Kinases, Ion Channels, and GPCRs, all following Rule-of-Five with >0.85 similarity to reference compounds.

8Custom Compound Database Generation
CategoryCustom Services
Description

Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

WuXi AppTec is a large CRO/CDMO with a compound supply and screening library business alongside broader discovery services. Comparable to Vitas-M in compound supply but operates at much greater scale and broader service scope, often chosen by pharma seeking integrated discovery outsourcing.

TypeDirect peer
Description

AK Scientific supplies building blocks, intermediates, and screening compounds globally via catalog and custom synthesis. Comparable to Vitas-M's BBL and STK offerings in customer base, product format options, and online ordering model.

TypeDirect peer
Description

Combi-Blocks manufactures and supplies organic building blocks and screening compounds for medicinal chemistry, with a focus on combinatorial and parallel synthesis. Direct competitor to Vitas-M's BBL building blocks offering and a frequent alternate source on pharma RFQs.

TypeDirect peer
Description

MolPort operates a chemical compound marketplace aggregating suppliers worldwide, with online search and order routing. Comparable to Vitas-M in serving medicinal chemists sourcing screening compounds and building blocks across pharma and academia.

TypeDirect peer
Description

Life Chemicals supplies screening libraries, focused/targeted libraries, and building blocks for HTS and medicinal chemistry. Direct competitor to Vitas-M across STK-style collections, targeted libraries, and custom compound requests from pharma and academic clients.

TypeDirect peer
Description

Specs is a long-standing compound library supplier offering screening compounds, building blocks, and target-focused libraries from the Netherlands. Closely comparable to Vitas-M in catalog type, customer base (pharma + academia), and historical footprint in European pharma procurement.

TypeDirect peer
Description

Enamine is the largest independent supplier of screening compounds and building blocks, with a catalog of several million molecules and in-house manufacturing capabilities. Directly comparable to Vitas-M's STK and BBL collections and frequently head-to-head on pharma procurement RFQs.

TypeDirect peer
Description

Otava offers small molecule screening libraries, focused/targeted libraries, and building blocks for drug discovery. Comparable product mix to Vitas-M across screening compounds and specialty libraries serving biotech and academic customers.

TypeBroad incumbent
Description

Sigma-Aldrich / MilliporeSigma is the broad incumbent life science reagent supplier offering screening compounds, building blocks, and fragment libraries as part of a much larger catalog. Competes with Vitas-M on procurement lists for pharma and academic customers but does not specialize in curated screening collections.

TypeDirect peer
Description

ChemSpace is an online marketplace and aggregator offering tens of millions of screening compounds and building blocks with self-service ordering. Competes with Vitas-M on catalog breadth, online UX, and global delivery for pharma and academic researchers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vitas-M Laboratory

Drug Discovery Chemical Compoundsvitasmlab.biz

Vitas-M Laboratory (Vitas M Chemical Limited) is a Hong Kong-based, privately held supplier of small molecule screening compounds, building blocks, and fragment libraries for pharmaceutical, agrochemical, and academic drug discovery research, offering over 1.4 million compounds globally since 1998.

What Vitas-M Laboratory does

Vitas-M Laboratory, legally Vitas M Chemical Limited, is a privately held Hong Kong-based supplier of small molecule chemical compounds for pharmaceutical and agrochemical research and development. Founded in 1998 by Irina Haywood and operating from Causeway Bay with 11–50 employees, the company has built a catalog of over 1,400,000 individual synthetic organic screening compounds, plus 20,000+ organic building blocks, a Rule-of-3-compliant fragment collection (Allium), three diversity libraries (10,000, 37,000, and 55,000 compounds), and more than 50 disease- and target-specific targeted libraries generated using in-house clustering and similarity-based computational algorithms.

The core technology is a curated physical chemical inventory packaged with online discovery tools. Researchers can access the catalog through a 24/7 self-service database (downloadable without registration), a property-based molecular search engine (filtering on H-bond donors, acceptors, rotatable bonds, rings, PSA, LogP, and molecular weight), SDF creation, and availability checking. Compounds are shipped worldwide via FedEx and UPS in dry powder or DMSO formats, with comprehensive documentation (SD files, packing lists, MSDS). In-house algorithms design diversity libraries by grouping molecules via clustering for maximal chemical-space coverage and generate targeted libraries using reference-compound similarity thresholds above 0.85 with Rule-of-Five compliance.

The commercial model is direct-to-researcher catalog sales with a quote-based pricing system (no publicly disclosed prices) and a secondary tier of professional services for custom database generation. Customers span pharmaceutical companies (Gilead Sciences, Eisai, Mochida), government translational research (NCATS), and academic institutions (Uppsala, University of Michigan, Griffith University, University of Eastern Finland) across at least nine countries. GTM combines self-service product-led growth with a dedicated sales email ([email protected]) for enterprise and custom orders. Revenue is not publicly disclosed and the company is bootstrapped with no institutional investors, parent company, or M&A activity on record.

Vitas-M Laboratory firmographics

Firmographics
Name
Vitas-M Laboratory
Legal name
Vitas M Chemical Limited
Website
https://vitasmlab.biz
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
Vitas-M Laboratory (Vitas M Chemical Limited) is a Hong Kong-based, privately held supplier of small molecule screening compounds, building blocks, and fragment libraries for pharmaceutical, agrochemical, and academic drug discovery research, offering over 1.4 million compounds globally since 1998.
Ownership category
akta.pro rank

Vitas-M Laboratory industry classification

Industry
Product category
Drug Discovery Chemical Compounds
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL)
akta.pro secondary industry
High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)

Keywords

  • Screening compounds
  • Fragment libraries
  • Organic building blocks
  • Drug discovery compounds
  • Small molecule libraries

Where Vitas-M Laboratory is headquartered

Location

Headquarters

HQ city
Causeway Bay
HQ country
Hong Kong SAR China
HQ region
Asia

Markets served

Vitas-M Laboratory business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

  1. Screening Compounds Sales: Direct sale of individual screening compounds (STK/STL collection) in dry powder or DMSO formats. Full cherry-picking access to entire catalog of 1,400,000+ compounds for immediate delivery.
  2. Organic Building Blocks Sales: Sale of BBL collection containing 20,000+ synthetic organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available in pack sizes of 500mg, 1g, and 2g.
  3. Fragment Library Sales: Fragment-based drug discovery compounds (Allium collection) compliant with Rule of 3. Offered in various formats including 384-well plates and custom quantities.
  4. Special Database Downloads: Specialized diversity and targeted compound libraries available for download. Includes Diversity_Vitas-10000 (10,000 compounds), Diversity_Vitas-37000 (7,000 compounds), and Diversity_Vitas-55000 (55,000 compounds) plus disease-specific targeted libraries.
  5. Custom Compound Database Generation: Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goRequest for Quotation (RFQ) system for compound orders

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Vitas-M Laboratory product offering

Product offering

Core offering

Vitas-M Laboratory supplies synthetic organic screening compounds, fragment libraries, and building blocks for small molecule drug discovery in the pharmaceutical and agrochemical industries. It offers a catalog of over 1,400,000 individual compounds along with diversity and disease-specific targeted libraries, delivered via self-service online download and direct courier shipping.

Product overview

Vitas-M Laboratory operates as a chemical compound supplier offering multiple product collections that serve as foundational research tools for pharmaceutical and agrochemical drug discovery. The core portfolio consists of the STK/STL screening compounds collection (1,400,000+ compounds) for biological assays and hit identification, the BBL building blocks collection (20,000+ compounds) for combinatorial and medicinal chemistry synthesis, and the Allium fragment collection for fragment-based drug discovery. These foundational products are complemented by specialized databases including three diversity libraries (Diversity_Vitas-10000, Diversity_Vitas-37000, Diversity_Vitas-55000) that provide structurally diverse compound sets with up to 55,000 molecules, and over 50 disease/target-specific targeted libraries designed using computational algorithms. The company provides online search tools, downloadable SDF files, and multiple delivery formats (dry powder, DMSO solutions, plates) to support researchers across the drug discovery workflow.

Differentiator

Problem solved

Functional benefit

Brands

  • STK: Stock screening compounds for biological assays and hit identification
  • BBL
  • Allium
  • Diversity_Vitas-10000
  • Diversity_Vitas-37000
  • Diversity_Vitas-55000

Products and services

  • STK/STL Collection (Screening Compounds) Stock of over 1,400,000 synthetic organic screening compounds available for immediate delivery, suitable for high-throughput screening, lead optimization, and medicinal chemistry workflows. Available in dry powder or DMSO solution formats.
  • Allium Fragment Collection Stock of fragments for Fragment Based Drug Discovery, compiled on the basis of Rule of 3 (Molecular weight < 300, ClogP < 3, H-bond donors < 3, H-bond acceptors < 3) and proprietary filters. Available as dry powder or DMSO solutions in various formats including 384-well plates.
  • BBL Collection (Building Blocks) Collection of more than 20,000 organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available as dry powder in 500mg, 1g and 2g pack sizes.
  • Diversity_Vitas-10000 Diversity library of 10,000 compounds designed for smaller-scale screening assays, emphasizing structural diversity using advanced clustering algorithms that group molecules by structural similarity.
  • Diversity_Vitas-37000 Expanded diversity collection of 7,000 compounds offering greater variety of pharmacophores and structural motifs for medium- to high-throughput screening efforts.
  • Diversity_Vitas-55000 Diversity library of 55,000 compounds incorporating wildcard molecules with unique or unconventional structures excluded from smaller libraries, designed for phenotypic screening and fragment-based discovery.
  • Targeted Libraries (disease/target-specific) Over 50 targeted molecular libraries designed using computational algorithms based on similarities with known active compounds. Libraries include Alzheimer's Disease, Cancer, Kinases, Ion Channels, and GPCRs, all following Rule-of-Five with >0.85 similarity to reference compounds.
  • Custom Compound Database Generation Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.

Quantifiable outcome

  • Over 1.4 million compounds available for immediate shipment
  • +2 more outcomes

Companies that use Vitas-M Laboratory

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Vitas-M Laboratory technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Vitas-M Laboratory partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Vitas-M Laboratory competitors and assessment

Company assessment

Broad incumbents

  • WuXi AppTec: WuXi AppTec is a large CRO/CDMO with a compound supply and screening library business alongside broader discovery services. Comparable to Vitas-M in compound supply but operates at much greater scale and broader service scope, often chosen by pharma seeking integrated discovery outsourcing.
  • Sigma-Aldrich (Merck): Sigma-Aldrich / MilliporeSigma is the broad incumbent life science reagent supplier offering screening compounds, building blocks, and fragment libraries as part of a much larger catalog. Competes with Vitas-M on procurement lists for pharma and academic customers but does not specialize in curated screening collections.

Direct peers

  • AK Scientific: AK Scientific supplies building blocks, intermediates, and screening compounds globally via catalog and custom synthesis. Comparable to Vitas-M's BBL and STK offerings in customer base, product format options, and online ordering model.
  • Combi-Blocks: Combi-Blocks manufactures and supplies organic building blocks and screening compounds for medicinal chemistry, with a focus on combinatorial and parallel synthesis. Direct competitor to Vitas-M's BBL building blocks offering and a frequent alternate source on pharma RFQs.
  • MolPort: MolPort operates a chemical compound marketplace aggregating suppliers worldwide, with online search and order routing. Comparable to Vitas-M in serving medicinal chemists sourcing screening compounds and building blocks across pharma and academia.
  • Life Chemicals: Life Chemicals supplies screening libraries, focused/targeted libraries, and building blocks for HTS and medicinal chemistry. Direct competitor to Vitas-M across STK-style collections, targeted libraries, and custom compound requests from pharma and academic clients.
  • Specs: Specs is a long-standing compound library supplier offering screening compounds, building blocks, and target-focused libraries from the Netherlands. Closely comparable to Vitas-M in catalog type, customer base (pharma + academia), and historical footprint in European pharma procurement.
  • Enamine: Enamine is the largest independent supplier of screening compounds and building blocks, with a catalog of several million molecules and in-house manufacturing capabilities. Directly comparable to Vitas-M's STK and BBL collections and frequently head-to-head on pharma procurement RFQs.
  • Otava Chemicals: Otava offers small molecule screening libraries, focused/targeted libraries, and building blocks for drug discovery. Comparable product mix to Vitas-M across screening compounds and specialty libraries serving biotech and academic customers.
  • ChemSpace: ChemSpace is an online marketplace and aggregator offering tens of millions of screening compounds and building blocks with self-service ordering. Competes with Vitas-M on catalog breadth, online UX, and global delivery for pharma and academic researchers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Vitas-M Laboratory social profiles

Digital presence

Vitas-M Laboratory financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vitas-M Laboratory leadership team

Management profile

Number of profiles

Profiles1 record

Vitas-M Laboratory funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vitas-M Laboratory M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitas-M Laboratory

What does Vitas-M Laboratory do?

Vitas-M Laboratory supplies synthetic organic screening compounds, fragment libraries, and building blocks for small molecule drug discovery in the pharmaceutical and agrochemical industries. It offers a catalog of over 1,400,000 individual compounds along with diversity and disease-specific targeted libraries, delivered via self-service online download and direct courier shipping.

Is Vitas-M Laboratory a public or private company?

Vitas-M Laboratory is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vitas-M Laboratory founded?

Vitas-M Laboratory was founded in 1998. It employs 11 to 50 people.

Where is Vitas-M Laboratory based?

Vitas-M Laboratory is headquartered in Causeway Bay, Hong Kong SAR China, in the Asia region.

How does Vitas-M Laboratory make money?

Five revenue lines are on record. Screening Compounds Sales are the primary driver. The others are organic Building Blocks Sales, fragment Library Sales, special Database Downloads and custom Compound Database Generation.

Who are Vitas-M Laboratory's main competitors?

Broad incumbents on record are WuXi AppTec and Sigma-Aldrich (Merck). Direct peers are AK Scientific, Combi-Blocks, MolPort, Life Chemicals, Specs, Enamine, Otava Chemicals and ChemSpace.

Does Vitas-M Laboratory have an API?

No public API is recorded for Vitas-M Laboratory.

What industry is Vitas-M Laboratory in?

Vitas-M Laboratory's product category is Drug Discovery Chemical Compounds. Its primary akta.pro industry code is HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries), with a secondary code of HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales